1-3 of 3
fidaxomicin
Close
Sort by
Journal Articles

Reconstruction of Human AML Reveals Stem Cell Origin and Therapeutic Targets for Treatment Resistant CD34 -/Lo MLL-Rearranged Leukemia

Tsz Kan Fung, Bernd Zeisig, Magdalena Zarowiecki, Huacheng Luo, Chiou Tsun Tsai, Boban Stanojevic, Claire Lynn, Anskar Y.-H. Leung, MD PhD, Jan Zuna, Marketa Zaliova, MD PhD, Martin Bornhaeuser, MD, Malte Von Bonin, Boris Lenhard, Suming Huang, PhD, Ghulam J. Mufti, Chi Wai Eric So
Journal: Blood
Blood (2019) 134 (Supplement_1): 3203.
https://doi.org/10.1182/blood-2019-125078
Published: 2019
Journal Articles

Safety and Efficacy of Fecal Microbiota Transplantation for Recurrent Clostridium Infection in Patients with Hematologic Malignancies

Mehrdad Hefazi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB, Mark R Litzow, MD, Darrell S Pardi, MD, Sahil Khanna, MBBS
Journal: Blood
Blood (2016) 128 (22): 3599.
https://doi.org/10.1182/blood.V128.22.3599.3599
Published: 2016
Journal Articles

A Subgroup Analysis of Patients Undergoing Autologous and Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Deflect-1: A Double-Blind, Randomized Study of Fidaxomicin Vs. Placebo for Prophylaxis Against C. Difficile Infection

Michael J Dugan, MD, Drew Winston, MD, Michele I Morris, MD, James E Williams, MD, Natasha Broyde, MS, Pamela Sears, PhD
Journal: Blood
Blood (2015) 126 (23): 390.
https://doi.org/10.1182/blood.V126.23.390.390
Published: 2015